You are viewing an incomplete version of our website. Please click to reload the website as full version.

Interleukin-1 Receptor-Associated Kinase 2 (IRAK2) (C-Term) Peptide

Details for Product No. ABIN1382040, Supplier: Log in to see
Protein Name
  • 6330415L08Rik
  • AI649099
  • IRAK-2
Protein Region
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-IRAK2 antibody (Interleukin-1 Receptor-Associated Kinase 2) (C-Term) (ABIN1030444)
Characteristics 20 amino acids near the carboxy terminus of human IRAK2.
Research Area Immunology, Innate Immunity, Cytokines, Receptors, Inflammation
Application Notes IRAK2 peptide is used for blocking the activity of IRAK2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Degli-Esposti, Smolak, Walczak, Waugh, Huang, DuBose, Goodwin, Smith: "Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family." in: The Journal of experimental medicine, Vol. 186, Issue 7, pp. 1165-70, 1997

Muzio, Ni, Feng, Dixit: "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling." in: Science (New York, N.Y.), Vol. 278, Issue 5343, pp. 1612-5, 1997

Sheridan, Marsters, Pitti, Gurney, Skubatch, Baldwin, Ramakrishnan, Gray, Baker, Wood, Goddard, Godowski, Ashkenazi: "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors." in: Science (New York, N.Y.), Vol. 277, Issue 5327, pp. 818-21, 1997